All Stories

  1. The role of high-frequency MRI monitoring in the detection of pathological brain atrophy in MS.

    Article • Journal of Neuroimaging, February 2018, Wiley

    Dejan Jakimovski, Dr. Tomas TU Uher

  2. Characteristics of motor speech phenotypes in multiple sclerosis

    Article • Multiple Sclerosis and Related Disorders, January 2018, Elsevier

    Dr. Tomas TU Uher

  3. Pathological cut-off values of global and regional brain atrophy in multiple sclerosis

    Article • Multiple Sclerosis Journal, November 2017, SAGE Publications

    Dr. Tomas TU Uher

  4. Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

    Article • BMC Neurology, July 2017, Springer Science + Business Media

    Dr. Tomas TU Uher

  5. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study

    Article • Journal of Neuroimaging, May 2017, Wiley

    Dejan Jakimovski, Dr. Tomas TU Uher

  6. GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study

    Article • Revue Neurologique, April 2017, Elsevier

    Dr. Tomas TU Uher

  7. Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

    Article • Journal of Lipid Research, December 2016, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr. Tomas TU Uher

  8. Identification of MS patients at highest risk of cognitive impairment using MRI volumetry.

    Article • European Journal of Neurology, November 2016, Wiley

    Dr Tomas Kalincik, Dr. Tomas TU Uher

  9. Reliable measurements of brain atrophy in individual patients with multiple sclerosis

    Article • Brain and Behavior, July 2016, Wiley

    Dr. Tomas TU Uher

  10. A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr. Tomas TU Uher, Dejan Jakimovski

  11. Combining clinical and MRI markers enhances prediction of 12-year disability in multiple sclerosis.

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr. Tomas TU Uher, Dr Tomas Kalincik

  12. Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr. Tomas TU Uher

  13. Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later

    Article • Multiple Sclerosis Journal, September 2015, SAGE Publications

    Dr. Tomas TU Uher, Dejan Jakimovski

  14. Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients

    Article • Journal of Lipid Research, August 2015, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr. Tomas TU Uher

  15. Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome

    Article • American Journal of Neuroradiology, June 2015, American Society of Neuroradiology (ASNR)

    Dr. Tomas TU Uher

  16. Predictors of disease activity in CIS (multiple sclerosis) patients

    Article • European Journal of Neurology, April 2015, Wiley

    Dr Tomas Kalincik, Dr. Tomas TU Uher, Dejan Jakimovski

  17. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment

    Article • Journal of the Neurological Sciences, December 2014, Elsevier

    Dr. Tomas TU Uher

  18. Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome

    Article • Journal of Neurology, June 2014, Springer Science + Business Media

    Dr Tomas Kalincik, Dr. Tomas TU Uher

  19. MRI correlates of disability progression in patients with CIS over 48 months

    Article • NeuroImage Clinical, January 2014, Elsevier

    Dr. Tomas TU Uher

  20. Neuropathic Pain, Depressive Symptoms, and C-Reactive Protein in Sciatica Patients

    Article • International Journal of Neuroscience, November 2012, Taylor & Francis

    Dr. Tomas TU Uher

  21. Cerebrospinal fluid S100B levels reflect symptoms of depression in patients with non-inflammatory neurological disorders

    Article • Neuroscience Letters, November 2012, Elsevier

    Dr. Tomas TU Uher

  22. Cerebrospinal fluid IL-8 levels reflect symptoms of alexithymia in patients with non-inflammatory neurological disorders

    Article • Psychoneuroendocrinology, September 2011, Elsevier

    Dr. Tomas TU Uher

  23. Alexithymia and Immune Dysregulation: A Critical Review

    Article • Activitas Nervosa Superior, March 2010, Springer Science + Business Media

    Dr. Tomas TU Uher